To evaluate the translational relevance of targeted EZH2 methyltransferase inhibition in LS, we first analyzed EZH2 mRNA expression in normal mucosa, adenoma (precancer), and adenocarcinoma samples from patients with LS treated at the University of Texas MD Anderson Cancer Center (MDACC) using RNA-Seq data. Here, EZH2 is linked to adenocarcinoma.